Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.

JOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.

Cell Adhesion & Migration, published by Taylor & Francis Inc, is a premier open access journal that has been providing a platform for the dissemination of high-quality research since its inception in 2007. With an emphasis on the critical roles that cell adhesion and migration play in various biological processes, this journal endeavors to publish cutting-edge studies in cell biology and cellular and molecular neuroscience. The journal's strong impact is reflected in its classification in the Q2 quartile for both Cell Biology and Cellular and Molecular Neuroscience categories as of 2023, underscoring its significance in advancing knowledge within the scientific community. The journal is accessible globally due to its open access model established in 2019, making it a valuable resource for researchers, professionals, and students aiming to explore innovative findings in cell dynamics and their implications in health and disease. With a commitment to fostering collaboration and dialogue among scientists, Cell Adhesion & Migration continues to be an essential resource in the rapidly evolving fields of cell biology and neuroscience.

Frontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.

Cell Regeneration, published by SPRINGERNATURE, stands at the forefront of biological research, focusing on the dynamic field of cellular development and regenerative biology. Since its establishment in 2012, this journal has embraced an Open Access model, facilitating widespread dissemination of key findings and fostering collaboration among researchers in the Netherlands and beyond. With an impact factor underscoring its significance, Cell Regeneration is positioned in the Q2 category in both Cell Biology and Developmental Biology as of 2023, ranked #32 out of 82 and #170 out of 285 in relevant Scopus peer fields. The journal encompasses a broad spectrum of research that advances our understanding of cellular processes, offering vital insights into regenerative mechanisms and their applications in therapies. This robust platform not only serves as a valuable resource for researchers, professionals, and students but also encourages scholarly dialogue and innovation in the fast-evolving landscape of cell biology.

APL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.